Connected Drug Delivery Devices Market is Expected to Reach USD 8,142.87 Million by 2033
IMARC Group has recently released a new research study titled “Connected Drug Delivery Devices Market Size, Share, Trends, and Forecast by Product, End User, Technology, and Region, 2025-2033”, offers a detailed analysis of the market drivers, segmentation, growth opportunities, trends and competitive landscape to understand the current and future market scenarios.
How Big Is the Connected Drug Delivery Devices Market?
The global connected drug delivery devices market size was valued at USD 1,081.78 Million in 2024. Looking forward, IMARC Group estimates the market to reach USD 8,142.87 Million by 2033, exhibiting a CAGR of 23.13% from 2025-2033. North America currently dominates the connected drug delivery devices market share, holding a market share of over 41.2% in 2024. The region’s connected drug delivery devices market share is driven by advancements in healthcare technology, high adoption of connected devices, increasing chronic disease prevalence, and supportive regulatory frameworks.
Global Connected Drug Delivery Devices Market Trends:
The growth of the connected drug delivery devices market is also driven by the increasing focus on patient-centric healthcare, the rise of telemedicine, and growing investment in digital therapeutics. These trends are fostering demand for smart, integrated drug delivery systems that enhance patient engagement and improve overall healthcare efficiency. In addition to this, the market is further supported by the aging global population, which requires more efficient chronic disease management, alongside advancements in AI and machine learning that enable predictive analytics in drug delivery. Additionally, regulatory incentives for digital health innovations are encouraging the adoption of connected drug delivery systems.
Factors Affecting the Growth of the Connected Drug Delivery Devices Industry:
- Advancements in digital health technologies:
The continuous evolution of digital health technologies has significantly propelled the connected drug delivery devices market. These devices are equipped with sensors, wireless communication capabilities, and mobile applications, enabling real-time monitoring and management of drug administration. The integration of these technologies allows for data collection on patient adherence, dosage accuracy, and overall treatment efficacy. The data can be analyzed to provide personalized feedback, enabling healthcare providers to make informed decisions regarding patient treatment plans. The advent of the Internet of Things (IoT) in healthcare has further facilitated the development of smart drug delivery systems that can communicate with other connected devices, enhancing the overall healthcare ecosystem.
- Increasing prevalence of chronic diseases:
The global rise in chronic diseases such as diabetes, asthma, cardiovascular diseases, and cancer is a significant factor driving the demand for connected drug delivery devices. These conditions often require long-term medication management, where patient adherence to prescribed treatments is crucial for effective disease management. Connected drug delivery devices help ensure that patients adhere to their medication schedules by providing reminders, alerts, and automatic dosage records. Additionally, these devices enable remote monitoring of patients, allowing healthcare providers to track their progress and intervene when necessary. The ability to manage chronic conditions more effectively through connected devices not only improves patient outcomes but also reduces healthcare costs by minimizing hospital visits and complications associated with poor medication adherence.
- Rising demand for personalized medicine:
The shift towards personalized medicine, where treatments are tailored to individual patients based on their genetic, environmental, and lifestyle factors, is another driving force behind the connected drug delivery devices market. These devices support personalized medicine by offering customizable drug delivery options that can be adjusted to meet the specific needs of each patient. For instance, connected inhalers can be programmed to deliver precise doses of medication based on the patient's respiratory patterns, while connected insulin pens can be tailored to deliver the exact amount of insulin required based on real-time glucose readings. This level of customization not only enhances treatment efficacy but also improves patient satisfaction by offering a more individualized approach to healthcare. As personalized medicine continues to gain traction, the demand for connected drug delivery devices is expected to grow, further driving market expansion.
Request to Get the Sample Report: https://www.imarcgroup.com/connected-drug-delivery-devices-market/requestsample
Connected Drug Delivery Devices Market Report Segmentation:
By Product:
- Connected Sensors
- Connected Inhaler Sensors
- Connectable Injection Sensors
- Integrated Connected Devices
- Connected Inhalation Devices
- Connected Injection Devices
Connected sensors represented the largest segment because they offer real-time monitoring and data collection, which is crucial for ensuring patient adherence and optimizing treatment outcomes.
By End User:
- Hospitals and Healthcare Providers
- Homecare
Bluetooth technology is widely adopted for its reliability and ease of integration in connecting drug delivery devices with mobile applications and other healthcare systems.
By Technology:
- Bluetooth
- NFC
- Other Technologies
Hospitals and healthcare providers rely heavily on connected drug delivery devices to enhance patient care and streamline medication management.
Regional Insights:
- North America (United States, Canada)
- Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, Others)
- Europe (Germany, France, United Kingdom, Italy, Spain, Russia, Others)
- Latin America (Brazil, Mexico, Others)
- Middle East and Africa
North America leads due to advanced healthcare infrastructure, high adoption of digital health technologies, and strong regulatory support for connected medical devices.
Top Connected Drug Delivery Devices Market Leaders:
The connected drug delivery devices market research report outlines a detailed analysis of the competitive landscape, offering in-depth profiles of major companies.
Some of the key players in the market are:
- Adherium Ltd.
- BioCorp Production
- Cohero Health Inc. (AptarGroup Inc.)
- Elcam Medical ACS. Ltd
- Findair Sp. z o. o.
- Merck KGaA
- Phillips Medisize (Molex LLC)
- Propeller Health (Resmed Inc.)
- Teva Pharmaceutical Industries Ltd.
- West Pharmaceutical Services Inc.
Ask An Analyst: https://www.imarcgroup.com/request?type=report&id=3738&flag=C
If you require any specific information that is not covered currently within the scope of the report, we will provide the same as a part of the customization.
About Us:
IMARC Group is a global management consulting firm that helps the world’s most ambitious changemakers to create a lasting impact. The company provide a comprehensive suite of market entry and expansion services. IMARC offerings include thorough market assessment, feasibility studies, company incorporation assistance, factory setup support, regulatory approvals and licensing navigation, branding, marketing and sales strategies, competitive landscape and benchmarking analyses, pricing and cost research, and procurement research.
Contact us:
IMARC Group
134 N 4th St. Brooklyn, NY 11249, USA
Email: sales@imarcgroup.com
Tel No:(D) +91 120 433 0800
United States: +1-631-791-1145
English
Français
Español
Português
Deutsch
Türkçe
Dutch
Italiano
Russian
Romaian